fwd: did you see our exclusive footage?

Forward to a Friend Having trouble viewing this issue? Click here. Refer a Friend to Energy and Capital. Did you see our exclusive footage? By Nick Hodge | Tuesday, September 30th, 2014 If you haven't seen the following, I suggest you check it out right away. It's just been released... but it already has everyone in the medical and investment communities talking. Why? It contains full, never-before-seen details on a development in the medical sector that could change our lives — and investments — forever... and possibly ruin them for those who don't see this. It's a very serious, life-changing situation involving reversing the symptoms of the world's worst diseases. Some celebrities, including Montel Williams — who has multiple sclerosis — have already used it with miraculous results. Early investors in the company behind it can expect a similar transformation in their lives. I sat down with Montel and the CEO of the company for an exclusive interview... so you could get all the information you need right from the source. I suggest you take a few minutes to see it now. You'll be as amazed as I was when I first heard about it. Call it like you see it, Nick Hodge Editor and Creator, Early Advantage This email was sent to ignoble.experiment@arconati.us. You can manage your subscription and get our privacy policy here. Energy and Capital, Copyright © 2014, Angel Publishing LLC, 111 Market Place #720, Baltimore, MD 21202. All rights reserved. No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. While we believe the sources of information to be reliable, we in no way represent or guarantee the accuracy of the statements made herein. Energy and Capital does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question. Unauthorized reproduction of this newsletter or its contents by Xerography, facsimile, or any other means is illegal and punishable by law. Please note: It is not our intention to send email to anyone who doesn't want it. If you're not sure why you're getting this e-letter, or no longer wish to receive it, get more info here, including our privacy policy and information on how to manage your subscription.